On the morning of July 11, 2022, Chairman of the Board of Directors of Beijing Zhongci Holding Group (hereinafter referred to as Zhongci Group), Zhao Chunshan , President Zhao Gang, Founder of Beijing Xiheniantang Traditional Chinese Medicine Hospital Chen Yongfei, General Manager of Marketing Center Wang Haiyan and others conducted a field investigation of Shenyang Feilong Pharmaceutical Holding Group (hereinafter referred to as Feilong Pharmaceutical). Wang Jinggang, Vice Chairman of Feilong Pharmaceutical and General Manager of Feilong Health (Shenyang) Co., Ltd., and Li Yunzhou, Deputy General Manager of Feilong Health (Shenyang) Co., Ltd., led the company's senior executives to enthusiastically contact.
Chairman Zhao Chunshan and his party visited the Feilong Pharmaceutical's development history exhibition hall, preparation workshop, packaging workshop, finished product workshop, laboratory, etc. accompanied by Chairman Wang Jinggang and his team, and had a multi-faceted understanding of Feilong Pharmaceutical's development history and overall profile.
Shenyang Feilong Pharmaceutical has three workshops: oral liquid, solid and external lining, and can produce 6 dosage forms of traditional Chinese medicine granules, hard capsules, mixtures, lining, tea and wine. It has more than 100 sets of analysis instruments such as high-performance liquid chromatography and gas chromatography . The product quality inspection is reliable, and it also has a total of 18 pure Chinese medicine varieties of "three series and three symptoms", of which 16 are exclusive products. Yuanhu Jigong Granules are exclusive dosage forms and national basic medicine catalog varieties. Chairman Zhao Chunshan expressed recognition and appreciation for Feilong Pharmaceutical's corporate R&D and production strength.
Chairman Wang Jinggang said: I have long heard that Chairman Zhao Chunshan of Zhongci Group is famous. He deeply respects Zhongci Group's 21-year development history of the big health industry and its leading position in the industry. He highly appreciates Zhongci Group's successful "Longevity Project", " Happiness Project ", and "Centenary Project" and other large-scale health charity projects. Therefore, cooperation with Zhongci Group is of great significance. At present, Feilong Pharmaceutical is preparing to focus on marketing and services to strengthen the promotion of the company's related special products. We especially hope to join forces with Zhongci Group, which has rich marketing experience and strong market resources, to seize the market opportunity of people paying more attention to health and quality in the post-epidemic era, so that the company's exclusive high-quality products can serve more people.
After friendly and in-depth talks, the two sides reached an agreement: Feilong Pharmaceutical and Zhongci Pharmaceutical, a subsidiary of Zhongci Group, adopt "R&D cooperation, laboratory sharing, production complementarity, publicity interaction, sales mutual assistance" and other methods to rely on each other and cooperate in depth. Let us jointly contribute to the health cause of Chinese people with high-quality products and high-quality services!
